Unknown

Dataset Information

0

Insulin therapy for pre-hyperglycemic beta-cell endoplasmic reticulum crowding.


ABSTRACT: Insulin therapy improves ?-cell function in early stages of diabetes by mechanisms that may exceed alleviation of glucotoxicity. In advance type 2 diabetes, hyperglycemia causes ?-cell damage and ultimately ?-cell loss. At such an advanced stage, therapeutic modalities are often inadequate. Growing evidence indicates that in early stages of type-2 diabetes and some types of monogenic diabetes linked with malfunctioning endoplasmic-reticulum (ER), the ?-cell ER fails to process sufficient proinsulin once it becomes overloaded. These changes manifest with ER distention (ER-crowding) and deficiency of secretory granules. We hypothesize that insulin therapy may improves ?-cell function by alleviating ER-crowding. To support this hypothesis, we investigated pre-diabetic ?-cell changes in hProC(A7)Y-CpepGFP transgenic mice that develop prolonged pre-diabetes due to proinsulin dysmaturation and ER-crowding. We attenuated the ?-cell ER proinsulin synthesis with a treat-to-target insulin therapy while avoiding hypoglycemia and weight gain. Alleviation of ER-crowding resulted in temporary improvement in proinsulin maturation, insulin secretion and glucose tolerance. Our observations suggest that alleviation of pre-diabetic ER-crowding using a treat-to-target insulin therapy may improve ?-cell function and may prevent further metabolic deterioration.

SUBMITTER: Absood A 

PROVIDER: S-EPMC3567120 | biostudies-other | 2013

REPOSITORIES: biostudies-other

altmetric image

Publications

Insulin therapy for pre-hyperglycemic beta-cell endoplasmic reticulum crowding.

Absood Afaf A   Gandomani Benjamin B   Zaki Anthony A   Nasta Vlad V   Michail Andrew A   Habib Peter M W PM   Hodish Israel I  

PloS one 20130207 2


Insulin therapy improves β-cell function in early stages of diabetes by mechanisms that may exceed alleviation of glucotoxicity. In advance type 2 diabetes, hyperglycemia causes β-cell damage and ultimately β-cell loss. At such an advanced stage, therapeutic modalities are often inadequate. Growing evidence indicates that in early stages of type-2 diabetes and some types of monogenic diabetes linked with malfunctioning endoplasmic-reticulum (ER), the β-cell ER fails to process sufficient proinsu  ...[more]

Similar Datasets

2015-11-16 | GSE74113 | GEO
| S-EPMC5758382 | biostudies-literature
| S-EPMC9807540 | biostudies-literature
| S-EPMC2661593 | biostudies-literature
| S-EPMC2570400 | biostudies-literature
| S-EPMC8085402 | biostudies-literature
| S-EPMC2940535 | biostudies-literature
| S-EPMC10138222 | biostudies-literature
| S-EPMC7851869 | biostudies-literature
| S-EPMC5672804 | biostudies-literature